IL13RA2 抗体
(8 references)Our Local Distributor
北京 101111
Quick Overview for IL13RA2 抗体 (ABIN1383686)
抗原
See all IL13RA2 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
特异性
- Recognises the IL-13 receptor a2 (IL-13 Ra2), a 44 kDa protein
-
纯化方法
- Ion exchange chromatography
-
过滤
- 0.22 μm filtered
-
免疫原
- IL-13Ra2 transfected CHO cell line,Myeloma X63/AG.8653 x Balb/c spleen cells
-
亚型
- IgG1 kappa
-
-
anti-Interleukin 13 Receptor, alpha 2 (IL13RA2) (AA 238-334) antibody
IL13RA2 适用: 人 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Interleukin 13 Receptor, alpha 2 (IL13RA2) (AA 27-126) antibodyIL13RA2 适用: 人 WB, ELISA, RNAi 宿主: 小鼠 Monoclonal 2E10 unconjugated
anti-Interleukin 13 Receptor, alpha 2 (IL13RA2) antibodyIL13RA2 适用: 人 WB, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Interleukin 13 Receptor, alpha 2 (IL13RA2) (AA 228-338) antibodyIL13RA2 适用: 小鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Interleukin 13 Receptor, alpha 2 (IL13RA2) (C-Term) antibodyIL13RA2 适用: 人, 小鼠, 大鼠 WB, ELISA, IF, ICC 宿主: 兔 Polyclonal unconjugated
anti-Interleukin 13 Receptor, alpha 2 (IL13RA2) (AA 27-343) antibodyIL13RA2 适用: 人 WB, ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Interleukin 13 Receptor, alpha 2 (IL13RA2) (AA 1-380) antibodyIL13RA2 适用: 人 WB, IP 宿主: 兔 Polyclonal unconjugated
anti-Interleukin 13 Receptor, alpha 2 (IL13RA2) (AA 1-380) antibodyIL13RA2 适用: 人 WB, FACS 宿主: 小鼠 Polyclonal unconjugated
anti-Interleukin 13 Receptor, alpha 2 (IL13RA2) (AA 81-180) antibodyIL13RA2 适用: 人, 小鼠 WB, ELISA, FACS 宿主: 兔 Polyclonal unconjugated
anti-Interleukin 13 Receptor, alpha 2 (IL13RA2) (AA 60-109) antibodyIL13RA2 适用: 人, 犬, 兔, Pig, 猴 WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Phosphate-buffered saline. Sterile-filtered through 0.22 μm. Carrier and preservative free
-
储存液
- Without preservative
-
储存条件
- 4 °C
-
储存方法
- Stable at +2-8°C for 12 months. For longer storage freeze aliquots.
-
-
-
: "Intratumoral therapy with IL13-PE38 results in effective CTL-mediated suppression of IL-13Ralpha2-expressing contralateral tumors." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 12, Issue 15, pp. 4678-86, (2006) (PubMed).
: "Specifically targeted killing of interleukin-13 (IL-13) receptor-expressing breast cancer by IL-13 fusion cytotoxin in animal model of human disease." in: Molecular cancer therapeutics, Vol. 3, Issue 2, pp. 137-47, (2004) (PubMed).
: "IL-4 and IL-13 up-regulate intestinal trefoil factor expression: requirement for STAT6 and de novo protein synthesis." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 172, Issue 6, pp. 3775-83, (2004) (PubMed).
: "Interleukin-13 receptor alpha2 chain in human head and neck cancer serves as a unique diagnostic marker." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 9, Issue 17, pp. 6381-8, (2003) (PubMed).
: "Heterogeneity in interleukin-13 receptor expression and subunit structure in squamous cell carcinoma of head and neck: differential sensitivity to chimeric fusion proteins comprised of interleukin-13 and a mutated form of Pseudomonas exotoxin." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 8, Issue 6, pp. 1948-56, (2002) (PubMed).
: "Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 169, Issue 1, pp. 407-14, (2002) (PubMed).
: "IL-13 receptor-targeted cytotoxin cancer therapy leads to complete eradication of tumors with the aid of phagocytic cells in nude mice model of human cancer." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 169, Issue 12, pp. 7119-26, (2002) (PubMed).
: "Interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas." in: Cancer research, Vol. 60, Issue 5, pp. 1168-72, (2000) (PubMed).
-
: "Intratumoral therapy with IL13-PE38 results in effective CTL-mediated suppression of IL-13Ralpha2-expressing contralateral tumors." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 12, Issue 15, pp. 4678-86, (2006) (PubMed).
-
- IL13RA2 (Interleukin 13 Receptor, alpha 2 (IL13RA2))
-
别名
- CD213a2
-
背景
- IL-13Ra2
-
分子量
- 74 kDa
抗原
-
